Junshi Biosciences and Coherus Share Update on the FDA
- FDA has been unable to travel to China to conduct the required site inspection resulting in delayed action on the BLA - - Junshi Biosciences and Coherus...
Source: globenewswire.com
Page 8 - Junshi Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Junshi Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Junshi Bioscience Today - Breaking & Trending Today
Coherus : FDA Delays Action On BLA For Toripalimab As Treatment For Nasopharyngeal Carcinoma
(RTTNews) - Shanghai Junshi Biosciences Co., Ltd and Coherus BioSciences Inc. (CHRS) said Sunday that they have not received an action letter from...
Source: businessinsider.com
Junshi Biosciences and Coherus Share Update on the FDA Review of the Biologics License Application (BLA) for Toripalimab as Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)
Junshi Biosciences and Coherus Share Update on the FDA Review of the Biologics License Application (BLA) for Toripalimab as Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) GlobeNewswire December 25, 2022 - FDA has been unable to travel to China to conduct the required site inspection resulting in delayed action on the...
Source: asiaone.com
Coherus and Junshi Biosciences Share Update on the FDA
- FDA has been unable to travel to China to conduct the required site inspection resulting in delayed action on the BLA - - Coherus and Junshi Biosciences...
Source: globenewswire.com
Coherus and Junshi Biosciences Share Update on the FDA Review of the Biologics License Application (BLA) for Toripalimab as Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)
24.12.2022 - - FDA has been unable to travel to China to conduct the required site inspection resulting in delayed action on the BLA - - Coherus and Junshi Biosciences are actively engaged in ongoing discussions with the FDA to support the inspections and gain ... Seite 1
Source: wallstreet-online.de